| Name | Title | Contact Details |
|---|
Nobu, the world-renowned Japanese restaurant recognized for pioneering a new-style Japanese cuisine, started as a business partnership in 1994 between Chef Nobu Matsuhisa and his partners, Academy Award-winning actor Robert De Niro, producer Meir Teper, and restaurateur Drew Nieporent. Originating in New York as the flagship restaurant, the Nobu brand is now an empire that spans five continents with over 40 restaurants and growing. Following the success of the restaurants, Nobu Hospitality opened the first Nobu Hotel in 2013 in Las Vegas and today has 13 hotels open with several more in development.
Meyer Laboratory, also known as Meyer Lab, is a U.S.-based chemical manufacturer that specializes in industrial and institutional cleaning chemicals and application systems. Founded in 1978 by Russ Meyer, the company has established itself as a leader in the North American market for industrial cleaning solutions. Meyer Lab focuses on delivering customized cleaning programs that meet the specific needs of its customers. The company offers a wide range of services, including tailored cleaning programs that aim to reduce chemical and labor costs, maintenance services for cleaning equipment, and training for effective product use. Meyer Lab also provides inventory management assistance and supplies advanced dispensing systems to enhance safety and efficiency in chemical use. Their product portfolio features various hard surface cleaning chemicals, such as degreasers, disinfectants, sanitizers, and surfactant blends, which are designed for multiple industrial and manufacturing markets. Meyer Lab is committed to supporting environmental initiatives by providing effective and efficient cleaning solutions.
Bimeda is an Ireland-based company that develops, manufactures and markets veterinary and animal care products.
ZEA manufactures plant biologics for pharmaceutical uses providing wellness to the world. At ZEA, we are uprooting medicine by growing plants and using our proprietary technology to produce medicinal plant products and we offer superior data analytics in what is a $400 billion dollar market.
Synonym is accelerating the worlds biological future by developing, financing and building commercial-scale biomanufacturing facilities. We provide synthetic biology (synbio) producers – from startups to the Fortune 500 – with flexible production capacity while giving infrastructure investors access to a new, carbon-negative biomanufacturing asset class that we are calling "fermentation farms".